Lymphotoxin beta‐activated <scp>LTBR/NIK/RELB</scp> axis drives proliferation in cholangiocarcinoma

Our study confirms that the non-canonical NF-κB axis LTβ/NIK/RelB drives cholangiocarcinogenesis and represents a candidate therapeutic target.

Authors

Institutions

Publication Details

Journal
Liver International
Published
2024-08-20
DOI
https://doi.org/10.1111/liv.16069
Citations
7
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
4.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma

Anna‐Lena Scherr, Dirk Jäger, Stefan Fröhling, Felix Korell et al.
7 citations
Liver International
Cholangiocarcinoma and Gallbladder Cancer Studies
4.01
article

Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma

Anna‐Lena Scherr, Dirk Jäger, Stefan Fröhling, Felix Korell, Christoph Springfeld, Thomas Albrecht, Annika Kessler, Mathias Heikenwälder, Stéphanie Roessler, Benjamin Goeppert, Eblina Kelmendi, Michael T. Dill, Bénédicte Lenoir, Osama Azzam Nieto, Nuria Vaquero‐Siguero, René Jackstadt, Nathalie Schmitt, Benjamin Sobol, Bruno Köhler, Ulrike Gärtner, María García‐Beccaria, Andreas Möck, Julia Volk, Federico Nichetti, Luisa Nader, H Isele, Maximilian Schwab, Pierluigi Ramadori, Danijela Heide, Jennifer Hüllein, Paula Hoffmeister‐Wittmann, Kaiyu Xu
article en
7 citations

Abstract

Our study confirms that the non-canonical NF-κB axis LTβ/NIK/RelB drives cholangiocarcinogenesis and represents a candidate therapeutic target.

Liver InternationalVol. 44(11)
Madrid Institute for Advanced Studies (ES), University of Bern (CH), German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), University Hospital Münster (DE), National Center for Tumor Diseases (DE), Klinikum Ludwigsburg (DE), DKFZ-ZMBH Alliance (DE), Heidelberg Institute for Stem Cell Technology and Experimental Medicine (DE), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Deutsches Konsortium für Translationale Krebsforschung (DE), Ludwig-Maximilians-Universität München (DE)
Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe
Good health and well-being
Openalex Percentile: Top 6%
Cholangiocarcinoma and Gallbladder Cancer Studies
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.